Table 3.
U-Cd (μg/g creatinine)-adjusted ORs for osteoporosis by outcome measure (data source), women ≥ 50 years of age.
Osteoporosis
|
Satterwaithe p-value | ||||
---|---|---|---|---|---|
Yes | No | OR | 95% CI | ||
Hip BMD (NHANES III, 1988–1994)a | |||||
Overall U-Cd | 579 | 2,247 | 1.15b | 1.00–1.33 | 0.05 |
≤0.50 μg/g | 110 | 643 | 1.00 | ||
0.50–1.0 μg/g | 228 | 839 | 1.43 | 1.02–2.00 | 0.04 |
>1.0 μg/g | 241 | 765 | 1.40 | 0.97–2.03 | 0.07 |
Respondent-reported physician-diagnosed osteoporosis (NHANES 1999–2004)c | |||||
Overall U-Cd | 184 | 741 | 1.65b | 1.07–2.54 | 0.02 |
≤0.50 μg/g | 82 | 386 | 1.00 | ||
0.50–1.0 μg/g | 69 | 250 | 1.46 | 0.84–2.55 | 0.18 |
>1.0 μg/g | 33 | 105 | 1.47 | 0.81–2.66 | 0.20 |
Adjusted for age, race, income, ever-smoker, and underweight.
OR for overall U-Cd interpreted per 1-μg/g creatinine increment.
Adjusted for age, race, income, ever-smoker, underweight, and survey-respondent–reported physician diagnosis of renal impairment.